SGLT2 inhibitor euglycaemic ketoacidosis — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Refer urgently for possible euglycaemic diabetic ketoacidosis and advise withholding empagliflozin during acute illness.
SGLT2 inhibitors can cause diabetic ketoacidosis with only modest glucose elevation. Vomiting, abdominal pain and rapid breathing are red flags requiring urgent assessment. Sick-day advice includes withholding SGLT2 inhibitors during acute dehydrating illness and seeking medical advice.
Reference: MHRA Drug Safety Update; BNF